Thu, Jul 10, 2014, 2:34 AM EDT - U.S. Markets open in 6 hrs 56 mins


% | $
Quotes you view appear here for quick access.

Isis Pharmaceuticals, Inc. Message Board

  • usagary1 usagary1 Dec 10, 2012 12:52 PM Flag

    Patent Problems with recent deal

    very possible...

    Inventors: Hong M. Moulton (Corvallis, OR, US) Ryszard Kole (Corvallis, OR, US)
    Assignees: AVI BIOPHARMA, INC.
    IPC8 Class: AA61K3808FI
    USPC Class: 514 164
    Class name:
    Publication date: 2012-03-08
    Patent application number: 20120058946

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • No let me say it again ,,,,,....NO

      Most likely they infringe on ISIS patent estate

    • You show an application. Not a patent. I cannot waste time on this, but you can log into public PAIR and look up something called the "image file wrapper". There, you may find a rejection notice.

      Either way, if ISIS has an older, more broad patent, its conceivable the parties you name could obtain a patent for a target, only to find the patent was wrongly issued. There is a long, difficult pathway for intellectual property developers and the patent office can issue a patent without knowing of another patent already issued, that covers the same thing or contemplated the same thing in the most broad read. Sorry, you cite essentially nothing but a date and a specification, which is worthless without an issued patent.

30.91-0.39(-1.25%)Jul 9 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.